Company Registration No. 12545252 (England and Wales)
Neurolistics Ltd
Unaudited accounts
for the year ended 31 August 2025
Neurolistics Ltd
Unaudited accounts
Contents
Neurolistics Ltd
Company Information
for the year ended 31 August 2025
Director
Dr Priyanka Pradhan
Company Number
12545252 (England and Wales)
Registered Office
Office 20, CP House
Otterspool Way
Watford
Herts
WD25 8HR
United Kingdom
Accountants
Peter Dell CCA
Office 20, CP House
Otterspool Way
Watford
Herts
WD25 8HR
Neurolistics Ltd
Statement of financial position
as at 31 August 2025
Tangible assets
17,323
16,057
Cash at bank and in hand
19,454
4,452
Creditors: amounts falling due within one year
2,032
4,689
Net current assets
30,166
11,941
Total assets less current liabilities
47,489
27,998
Provisions for liabilities
Deferred tax
(3,259)
(3,050)
Called up share capital
100
100
Profit and loss account
44,130
24,848
Shareholders' funds
44,230
24,948
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 30 August 2025 and were signed on its behalf by
Dr Priyanka Pradhan
Director
Company Registration No. 12545252
Neurolistics Ltd
Notes to the Accounts
for the year ended 31 August 2025
Neurolistics Ltd is a private company, limited by shares, registered in England and Wales, registration number 12545252. The registered office is Office 20, CP House, Otterspool Way, Watford, Herts, WD25 8HR, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% Reducing balance
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
Neurolistics Ltd
Notes to the Accounts
for the year ended 31 August 2025
4
Tangible fixed assets
Plant & machinery
At 1 September 2024
22,540
Amounts falling due within one year
6
Creditors: amounts falling due within one year
2025
2024
Trade creditors
1,234
1,600
Taxes and social security
10,450
2,477
Loans from directors
(15,000)
(10,000)
7
Deferred taxation
2025
2024
Accelerated capital allowances
3,259
3,050
Provision at start of year
3,050
3,668
Charged/(credited) to the profit and loss account
209
(618)
Provision at end of year
3,259
3,050
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
Neurolistics Ltd
Notes to the Accounts
for the year ended 31 August 2025
Brought
Forward
Advance/
credit
Repaid
Carried
Forward
Directors loan
10,000
5,000
-
15,000
At the year end the director owed the company £15,000. This loan was repaid by way of dividend on 6 April 2026.
10
Transactions with related parties
During the period to 31 August 2025 the company paid a dividend of £24,500.
11
Average number of employees
During the year the average number of employees was 1 (2024: 1).